Grü­nen­thal inks a deal with Vali­nor; Val­ne­va gets $41M from CEPI

Plus, news about Cel­lec­tar Bio­sciences and In­novent:

Grü­nen­thal ac­quires Vali­nor Phar­ma for $250M: Grü­nen­thal is set to be­come the “glob­al own­er” of the US biotech …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER